Consumer health staple giant gets a big inside buy ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Tuesday, December 16, 2025
|
|
|
Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves. 📌 Kenvue $KVUE — Starboard Value LP disclosed a Form 4 purchase totaling $110.99 Million.
A massive transaction that immediately stands out in a defensive consumer staple. This is sizing that reflects strategic intent, not passive exposure. 📌 Amcor Plc $AMCR — CFO Stephen R. Scherger bought $1,006,982 in his latest Form 1. When the company's top financial executive steps in with size, it's always worth paying attention. Here's The Hot Corner, with data from December 15, 2025: |
Click the table to enlarge it. |
📌 Kymera Therapeutics $KYMR — Biotechnology Value Fund lifted its 13D stake from 7.22% to 8.50%.
Specialist biotech capital pressing its position as the stock continues to push into all-time highs. 📌 NextDecade $NEXT — Hanwha Aerospace disclosed a Form 4 purchase of $9.40 Million.
Continued accumulation from the Korean giant in this strategic partner. | |
|
Alfonso De Pablos | Director of Research, All Star Charts |
|
|
Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media. |
Want to change how you receive these emails? You can manage your preferences here unsubscribe. © 2025 Stock Market Media 624 Broadway, Suite 405 San Diego, CA 92101 |
|
|
|